![]() | This article contains paid contributions. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. |
Submission declined on 24 July 2023 by The4lines (talk). This submission does not appear to be written in the formal tone expected of an encyclopedia article. Entries should be written from a neutral point of view, and should refer to a range of independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
| ![]() |
Submission declined on 13 July 2023 by KylieTastic (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by KylieTastic 13 months ago.
| ![]() |
Submission declined on 4 July 2023 by RoboCric (talk). This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies. Declined by RoboCric 13 months ago. | ![]() |
Comment: Just blatant advertising...start again WP:TNT. Theroadislong (talk) 13:16, 21 March 2024 (UTC)
Comment: Sources are either not about the subject or PR KylieTastic (talk) 16:15, 13 July 2023 (UTC)
Comment: Please add some more reliable sources covering independently about the subject. See WP:NORG. And it doesn't comply with WP:MOS either. First, give a short summary of the company. Then create a separate section for its history. Write the significant events in a single paragraph other than writing those in points. RoboCric Let's chat 10:16, 4 July 2023 (UTC)
ModuleMD is an American software company headquartered in Grand Blanc, Michigan. In the 1990s, two allergists identified a need for comprehensive software to help medical practices manage patient records and increase efficiency. Since then, ModuleMD has helped hundreds of practices manage more than 10 million medical records.
Company History
editBefore launching a product, the ModuleMD team spent two years collecting feedback from physicians and other healthcare providers, enhancing their understanding of the market’s needs and pain points. Based on that feedback, ModuleMD rolled out an SaaS solution for its first customer in 2002. Just seven years later, ModuleMD integrated with an ePrescribe partner to give users seamless prescribing capabilities.
In 2009, Congress passed the Health Information Technology for Economic and Clinical Health (HITECH) Act. As part of the HITECH Act, the Centers for Medicare & Medicaid Services introduced the Meaningful Use program,[1] which required providers to demonstrate meaningful use of electronic health records (EHR). The ModuleMD team saw an opportunity to help medical practices comply with the new requirements, prompting them to obtain the Meaningful Use Stage I Certification from the Office of the National Coordinator for Office of the National Coordinator for Health Information Technology (ONC) in 2011.[2]
Between 2011 and 2017, ModuleMD earned two additional ONC certifications. It was the first EHR to automatically upload data to the American Academy of Allergy, Asthma and Immunology Registry for specialty-specific criteria, as well as the first EHR to partner with regional health information exchanges, enabling physician practices to connect to larger health systems. In 2018, the ModuleMD team turned its attention to the future of telehealth. Company executives realized more patients were asking for telemedicine services to make it easier to access quality healthcare. As a result, ModuleMD incorporated telehealth features into its platform.
The National Committee for Quality Assurance started its Patient-Centered Medical Home Recognition Program in 2008.[3] To qualify as a medical home a provider must meet several criteria. Some of the requirements focus on the use of EHR to increase access to clinical advice,[4] share information with other healthcare professionals and make better clinical decisions. In 2019, ModuleMD earned its prevalidation status to help practices meet these PCMH requirements. In a bid to promote technological innovation, Silverstone Capital acquired ModuleMD in 2021. Since then, ModuleMD has continued to expand its service offerings, adding remote patient monitoring features in 2022.
References
edit[1] [2] [3] [4] [5] [6] [7] [8] [9] [10]
- ^ "ONC-certified EHR Software ModuleMD Partners with Chronic Care Management Software Well Living Initiative" (Press release).
- ^ "ModuleMD Earns 2023 Great Place to Work Certification™ in healthcare". 7 June 2023.
- ^ "Module MD Pricing, Alternatives & More 2024".
- ^ https://www.aaaai.org/allergist-resources/digital-medicine-ehr/allergy-specific-information
- ^ "False".
- ^ "Portfolio Companies".
- ^ "Abhinay Rao Penugonda | CEO - ModuleMD".
- ^ https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Practice%20Management/Quality%20Clinical%20Data%20Registry/AAAAI_QCDR_2016_Registry_Webcast_September_2016_FINAL.pdf
- ^ "Prevalidated Vendor Directory".
- ^ "Certified Health IT Product List (CHPL)".